We Make Medicine

 

At Teva Canada, we believe that all Canadians deserve access to innovative and affordable medications. We develop, produce and market generic pharmaceuticals, from diabetic agents to antibiotics, from heart medications to cancer treatments. We’ve been part of Canadian healthcare since 1965, when we began operations as one of the country’s first generic pharmaceutical companies. Today, we employ over 1,500 Canadians. We invest in facilities in this country—creating generic and brand-name medications. And we’re proud to be part of Teva Pharmaceutical Industries Ltd. Worldwide, Teva is the leader in generics, one of the top 10 pharmaceutical companies, active in 60 countries and a workplace of choice for 46,000 dedicated employees.

We are motivated by a passion to make a difference.

News

 
GM December 8, 2014

Doug Sommerville announces the launch of PrTeva-Erlotinib, a generic of PrTarceva®

"Teva Canada’s industry-leading oncology portfolio is helping to mitigate the rising costs of cancer treatment in Canada." > more

December 8, 2014

Introducing PrTeva-Erlotinib

A generic alternative to PrTarceva®. Product information and full monograph available. > more